메뉴 건너뛰기




Volumn 26, Issue 1, 2016, Pages 154-159

Cross metathesis with hydroxamate and benzamide BOC-protected alkenes to access HDAC inhibitors and their biological evaluation highlighted intrinsic activity of BOC-protected dihydroxamates

Author keywords

Cancer; Histone deacetylases; Metathesis; Tubulin

Indexed keywords

ALKENE; BENZAMIDE; BENZAMIDE DERIVATIVE; CARBONYL DERIVATIVE; HISTONE DEACETYLASE 6; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID; HYDROXAMIC ACID DERIVATIVE; PHENYLENEDIAMINE; TACEDINALINE; TERT BUTYLOXYCARBONYL; TRICHOSTATIN A; TUBULIN; UNCLASSIFIED DRUG; VORINOSTAT; FORMIC ACID DERIVATIVE; HISTONE DEACETYLASE; T-BUTYLOXYCARBONYL GROUP;

EID: 84949623954     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2015.11.011     Document Type: Article
Times cited : (12)

References (42)
  • 15
    • 84928774345 scopus 로고    scopus 로고
    • R. Poole Drugs 74 2014 1543
    • (2014) Drugs , vol.74 , pp. 1543
    • Poole, R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.